Any Cell. Any Molecule. Any Scale. ®

Leading proprietary cell-engineering electroporation technology. Advancing next-generation cell therapies from concept to clinical trials and manufacturing.

Slide Slide Slide

Your Proven Partner from
Concept to Clinic

  • High Efficiency

  • Reproducibility

  • Enhanced Potency

  • Scalable

  • Non-toxic

  • Minimal Negative Effect
  • Physiology / Phenotype

  • Purity / Function

  • Technical Support

  • Regulatory Support

  • Provide FTO

  • Clinical Support

  • GMP

  • Regulatory master file

  • Enhanced Potency

  • Scalable

A proven partner, with aligned goals, to provide technical,
regulatory and clinical support

Supported by numerous publications, clinical trials, and 100+ licensed for clinical use, our ExPERT® family of electroporation instruments deliver robust performance, efficiency, flexibility, and scalability to propel promising new therapies from concept to clinic.

The development of novel and efficacious therapies is dependent on a strong technological platform to bring your ideas from bench to bedside. The ability to quickly optimize experimental or manufacturing parameters help enable the rapid and cost-effective development of therapies to use safely in clinical trials.

Learn more or download or select case studies.

Any Cell.

Electroporation/non-viral approach with broad cell compatibility

Slide Slide Slide Slide Slide Slide

Any Molecule.

Transfect any molecule with the MaxCyte® ExPERT® platform

Ion channels GPCRs Transporters Receptors

Enzymes Reporters Transcription factors Epigenetic regulators

CRISPR/Cas9 ZFNs TALENs siRNAs/ASOs

Lentivirus/AAV Alphavirus Adenovirus VLPs Subunit vaccines

Antibodies Bi-specifics Fusion proteins Antigens Cell lines

Any Scale.

Seamless scalability from thousands to billions of cells

Selected Case Study

Case Study Gene Knock-in via Homology-directed Repair in Human iPSCs

Case Study CRISPR mRNA & RNP Delivery

Engineering NK Cells

Ease of use

The ExPERT® family of instruments provides enhancements that improve ease of use, processing workflow, regulatory compliance, and overall user experience with its elegant design that fits seamlessly into any high-tech laboratory space.

  • 21 A Tr CFR Part 11 – Security
    Password controlled access Defined roles and permissions

  • 21 CFR Part 11 – Traceability
    Audit trails
    Track all events

Established regulatory path

  • cGMP Compliant
  • Master File with US FDA and Health Canada

MaxCyte® provides a complete solution from electroporation technology to consumables and, most importantly, partnership.

Our Field Application Service is able to assist you in the development and optimization of your protocols or designing a custom solution.

Which instrument is right for you?

  • Seamless scalability from 50,000 to 20,000,000,000 cells means no re-optimization upon scaling up.
  • Superior transfection efficiency and/or viability compared to competing platforms for most applications.
  • One universal electroporation buffer for all cell types and applications.
  • On-demand user training, technical support, and scientific support so you have the help you need when you need it.
  • cGMP compliance and FDA Master File for expedited regulatory approval when translating for clinical us.

MaxCyte, Inc.

22 Firstfield Road, Suite 110
Gaithersburg, MD 20878
Tel: +1-301-944-1700
Fax: +1-301-944-1703